Edesa Biotech completes financing to develop novel dermatology and anorectal treatments

by Inveready

Edesa Biotech Inc., a clinical-stage private company announced today the completion of a $7 million Series A financing. The internationally syndicated investment was led by Lumira Capital and included...

Read more
Subscribe to Directory
Write an Article

Highlight

3i closes second European CLO, Harvest V...

by 3i Group

3i Group plc (“3i” or “3i Group”), an international investor, ...

3P Biopharmaceuticals incorpora a Keensi...

by Professional Newco

3P Biopharmaceuticals (3P), compañía especializada en el desarrollo ...

Photos Stream